Si-Bone Inc. ’s fourth quarter (Nasdaq: SIBN) got off to a good start in October after the U.S. Food and Drug Administration ...
The study, published today in JAMA Network Open, tracked patients hospitalized for hip fractures in Victoria, Australia from March 2013 through June 2018, who had used gabapentinoids before the injury ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback